Patent application number | Description | Published |
20080227784 | N-(3,4-disubstituted phenyl) salicylamide derivatives - A compound represented by the following formula (I) or a salt thereof: | 09-18-2008 |
20080234233 | MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES - A medicament for preventive and/or therapeutic treatment of neurodegenerative diseases such as Alzheimer's disease or the like which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: | 09-25-2008 |
20080249071 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR - A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient: | 10-09-2008 |
20080249175 | N-Phenyloxamide derivatives - A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): | 10-09-2008 |
20080275116 | Carboxilic acid derivatives - A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): | 11-06-2008 |
20080311074 | Inhibitors against activation of NF-kappaB - A method of inhibiting NF-κB activation in a mammal including a human, which comprises the step of administering an effective dose of a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: | 12-18-2008 |
20080318956 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR - A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient: | 12-25-2008 |
20090192122 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR -
A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient:
| 07-30-2009 |
20090215899 | N-Phenyloxamide derivatives - A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): | 08-27-2009 |
20090239868 | INHIBITOR OF PAI-1 PRODUCTION - The compound represented by the following general formula (I) has an inhibitory activity on PAI-1 production; | 09-24-2009 |
20090312315 | PAI-1 INHIBITOR - The compound represented by the following formula (I) and the like have PAI-1 inhibition activity; | 12-17-2009 |
20100113448 | OXAZOLIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 - Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor. | 05-06-2010 |
20100113770 | O-SUBSTITUTED HYDROXYARYL DERIVATIVES - A medicament having inhibitory activity against NF-κB activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: | 05-06-2010 |
20100234363 | HETEROCYCLIC DERIVATIVE HAVING INHIBITORY ACTIVITY ON TYPE-I 11 DATA-HYDROXYSTEROID DEHYDROGENASE - Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor. | 09-16-2010 |
20100274051 | INFLAMMATORY CYTOKINE RELEASE INHIBITOR - A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or α pharmacologically acceptable salt as an active ingredient: | 10-28-2010 |
20110294813 | OXAZOLIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 - Disclosed is a compound which is useful as an 11β-hydroxysteroid dehydrogenase type 1 inhibitor. | 12-01-2011 |